Summary
Updated Aug 30, 2026
James J. Doherty is President and CDO of Acumen Pharmaceuticals, Inc. (ABOS). 1 SEC Form 4 filing on record, dated 21 January 2026.
Recent Transactions
1Every recent SEC Form 4 transaction James J. Doherty has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies James J. Doherty files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Derek M. Meisner - $105K of ABOS open-market activity in the last 12 months
- Derrell Porter - $75K of ABOS open-market activity in the last 12 months
- Daniel Joseph Oconnell - $22K of ABOS open-market activity in the last 12 months
- Nathan B. Fountain - $14K of ABOS open-market activity in the last 12 months
- Matt Zuga - $8K of ABOS open-market activity in the last 12 months
- Eric Siemers - $6K of ABOS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is James J. Doherty?
James J. Doherty is a corporate insider, tracked as President and CDO of Acumen Pharmaceuticals, Inc. (ABOS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did James J. Doherty last file a Form 4?
The only primary Form 4 on record is dated 21 January 2026.
Where can I see all of James J. Doherty's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow James J. Doherty and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
